CLEMENTIA PHARMACEUTICALS IN - COM (CMTA)

CUSIP: 185575107

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
23,556,213
Share change
+717,291
Total reported value
$262,650,725
Price per share
$11.15
Number of holders
26
Value change
+$6,477,827
Number of buys
11
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 185575107?
CUSIP 185575107 identifies CMTA - CLEMENTIA PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEMENTIA PHARMACEUTICALS IN - COM (CMTA) as of Q3 2018

As of 30 Sep 2018, CLEMENTIA PHARMACEUTICALS IN - COM (CMTA) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,556,213 shares. The largest 10 holders included ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, NEA Management Company, LLC, BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, DRIEHAUS CAPITAL MANAGEMENT LLC, Artal Group S.A., FEDERATED INVESTORS INC /PA/, and Rock Springs Capital Management LP. This page lists 26 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.